Company · CIK 1621227
Adaptimmune Therapeutics PLC
| CIK | 1621227 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | X0 |
| Listed | ADAPY (OTC) |
| First annual or quarterly report | 2015-10-13 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-286639 | 2025-04-18 | 2026-04-22 | 3 | |
| 333-264208 | 2022-04-08 | 2022-04-28 | 3 | |
| 333-243743 | 2020-08-10 | 2020-08-10 | 1 | |
| 333-233557 | 2019-08-30 | 2020-06-02 | 6 | |
| 333-226147 | 2018-07-12 | 2018-09-05 | 2 | |
| 333-212713 | 2016-07-28 | 2017-04-05 | 5 | |
| 333-203267 | 2015-04-06 | 2015-05-07 | 5 |
Filings
28| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-22 | RWWithdrawn | 333-286639 | 0001104659-26-046473 |
| 2025-11-14 | EFFECTDeclared effective | 333-286639 | 9999999995-25-003290 |
| 2025-04-18 | S-3Shelf registered | 333-286639 | 0001104659-25-036359 |
| 2023-04-20 | EFFECTDeclared effective | 333-271145 | 9999999995-23-000997 |
| 2022-04-28 | 424B5Shelf takedown | 333-264208 | 0001104659-22-051654 |
| 2022-04-22 | EFFECTDeclared effective | 333-264208 | 9999999995-22-001066 |
| 2022-04-08 | S-3Shelf registered | 333-264208 | 0001104659-22-044275 |
| 2020-08-10 | S-3ASRShelf registered | 333-243743 | 0001104659-20-092818 |
| 2020-06-02 | 424B5Shelf takedown | 333-233557 | 0001047469-20-003304 |
| 2020-06-01 | 424B5Shelf takedown | 333-233557 | 0001047469-20-003280 |
| 2020-01-22 | 424B5Shelf takedown | 333-233557 | 0001047469-20-000402 |
| 2020-01-21 | 424B5Shelf takedown | 333-233557 | 0001047469-20-000356 |
| 2019-09-10 | EFFECTDeclared effective | 333-233557 | 9999999995-19-002055 |
| 2019-08-30 | S-3Shelf registered | 333-233557 | 0001104659-19-048197 |
| 2018-09-05 | 424B5Shelf takedown | 333-226147 | 0001047469-18-005954 |
| 2018-07-12 | S-3ASRShelf registered | 333-226147 | 0001047469-18-005006 |
| 2017-04-05 | 424B5Shelf takedown | 333-212713 | 0001047469-17-002347 |
| 2017-03-22 | 424B5Shelf takedown | 333-212713 | 0001047469-17-001894 |
| 2017-03-21 | 424B5Shelf takedown | 333-212713 | 0001047469-17-001854 |
| 2016-09-12 | EFFECTDeclared effective | 333-212713 | 9999999995-16-005670 |
| 2016-07-28 | S-3Shelf registered | 333-212713 | 0001047469-16-014500 |
| 2015-05-07 | 424B4Final prospectus | 333-203267 | 0001047469-15-004459 |
| 2015-05-06 | EFFECTDeclared effective | 333-203642 | 9999999995-15-001245 |
| 2015-05-05 | EFFECTDeclared effective | 333-203267 | 9999999995-15-001227 |
| 2015-05-01 | F-1/AAmendment | 333-203267 | 0001047469-15-004272 |
| 2015-04-27 | F-1/AAmendment | 333-203267 | 0001047469-15-003918 |
| 2015-04-06 | F-1Registration filed | 333-203267 | 0001047469-15-003218 |
| 2015-02-05 | DRSDraft made public | 377-00913 | 0000912057-15-000017 |